0
Aurinia Pharmaceuticals Inc. Banner Image

Aurinia Pharmaceuticals Inc.

  • Ticker AUPH
    Exchange NASDAQ More
  • Industry Biotechnology More
  • Sector Healthcare More
Aurinia Pharmaceuticals Inc. Logo Image
  • 201-500 Employees
  • Based in Victoria, British Columbia
Aurinia Pharmaceuticals is a clinical stage biopharmaceutical company focused on developing and commercializing therapies to treat targeted patient populations that are suffering from serious diseases with a high unmet medical need. The company is currently developing voclosporin, an investigational drug, for the potential treatment of lupus nephritis and Dry Eye Syndrome. The company isMore headquartered in Victoria, British Columbia, its U.S. commercial hub in Rockville, MD, and focuses its development efforts globally.
Aurinia Pharmaceuticals Inc.

Most Recent Responsibility Report

Aurinia Pharmaceuticals Inc.
MOST RECENT 2022 ESG Report
Our service enables potential investors to review the most recent and archived Aurinia Pharmaceuticals Inc. Sustainability Report, Aurinia Pharmaceuticals Inc. Corporate Social Responsibility Report, Aurinia Pharmaceuticals Inc. CSR Report, Aurinia Pharmaceuticals Inc. Corporate Responsibility, Aurinia Pharmaceuticals Inc. CR Report, Aurinia Pharmaceuticals Inc. Citizenship Report, Aurinia Pharmaceuticals Inc. ESG Report, and Aurinia Pharmaceuticals Inc. Environmental Report online.
Aurinia Pharmaceuticals Inc. Logo Image

Rate This Report

Your vote helps our reports be more useful
Rating Saved!

Thank you for your feedback!